Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question 💭
Wheaton, IL
November 2, 2025
 · 
Be the first to react
A MyLymphomaTeam Member

HarryKobetitsch,
Hi and welcome to the site. Everyone here is helpful and supportive. I have/had DLBCL stage IV and had treatments of rchop chemo. I hope you have a relaxing day. Kelly

November 2, 2025
MyLymphomaTeam

What is the prognosis for double-hit DLBCL?

Double-hit lymphoma (DHL) in DLBCL tends to have a more challenging prognosis compared to standard DLBCL. The genetic mutations involving MYC and BCL2 genes can lead to a more aggressive cancer that's harder to treat.

A 2014 study showed that after two years, 50 percent of Show Full Answer

What is the prognosis for double-hit DLBCL?

Double-hit lymphoma (DHL) in DLBCL tends to have a more challenging prognosis compared to standard DLBCL. The genetic mutations involving MYC and BCL2 genes can lead to a more aggressive cancer that's harder to treat.

A 2014 study showed that after two years, 50 percent of people with DHL were still alive, and of these, 40 percent had not shown signs of disease progression. This is generally lower than the survival rates for standard DLBCL, which has a five-year survival rate of about 65 percent.

DHL is often refractory, meaning it may not respond as well to initial treatment. Even when there's an initial response, the cancer often relapses and returns. Due to its aggressive nature, people diagnosed with DHL typically require intensive treatment regimens.

However, it's important to know that cancer treatments are constantly improving. New therapies and treatment approaches may be enhancing outcomes for people with DHL. Talk to your doctor about the latest treatment options and how they might improve your individual outlook.

November 2, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Ridgewood, NJ

A MyLymphomaTeam Member asked a question 💭